Synthesis and Biopharmaceutical Evaluation of Imatinib Analogues Featuring Unusual Structural Motifs-Reference-Cited by-同舟云学术

Synthesis and Biopharmaceutical Evaluation of Imatinib Analogues Featuring Unusual Structural Motifs

Published:2015-11-20 Issue:1 Volume:11 Page:31-37
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Nicolaou Kyriacos C.¹,Vourloumis Dionisios¹²,Totokotsopoulos Sotirios¹,Papakyriakou Athanasios²,Karsunky Holger³,Fernando Hanan³,Gavrilyuk Julia³,Webb Damien⁴,Stepan Antonia F.⁴

Affiliation:

1. Department of Chemistry; Rice University; 6100 Main Street Houston TX 77005 USA

2. Laboratory of Chemical Biology of Natural Products & Designed Molecules; National Centre of Scientific Research (NCSR) “Demokritos”; Agia Paraskevi Athens 15310 Greece

3. Stemcentrx, Inc.; 450 East Jamie Court San Francisco CA 94080 USA

4. Pfizer Worldwide Research & Development; 610 Main Street Cambridge MA 02139 USA

Funder

Cancer Prevention & Research Institute of Texas (CPRIT), USA

The Welch Foundation

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Reference43 articles.

1. Tyrphostins and Other Tyrosine Kinase Inhibitors

2. Treatment for chronic myelogenous leukemia: the long road to imatinib